NEWS

TileDB, Kepler AI, and Tahoe Therapeutics Partner to Transform Single-Cell Data Analysis with AI-Powered Platform
TileDB, Kepler AI, and Tahoe Therapeutics Partner to Transform Single-Cell Data Analysis with AI-Powered Platform 10/20/2025
MindRhythm’s Harmony for Prehospital Large Vessel Occlusion Stroke Identification Submitted for FDA Clearance
MindRhythm’s Harmony for Prehospital Large Vessel Occlusion Stroke Identification Submitted for FDA Clearance 10/20/2025
Oculinea, Inc. Enters into Research Agreement with Trican Biotechnology Pipeline
Oculinea, Inc. Enters into Research Agreement with Trican Biotechnology Pipeline 09/25/2025
Landmark UCSF Study Demonstrates Functional Rescue of SCN2A Loss of Function, Underscoring the Potential of Regel Therapeutics' Targeted EpiEditing Platform
Landmark UCSF Study Demonstrates Functional Rescue of SCN2A Loss of Function, Underscoring the Potential of Regel Therapeutics' Targeted EpiEditing Platform 09/19/2025
Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases
Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases 09/03/2025
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia 09/02/2025
Venova Medical Receives FDA IDE Approval for the VENOS-3 Pivotal Study of the Velocity™ Percutaneous AVF System
Venova Medical Receives FDA IDE Approval for the VENOS-3 Pivotal Study of the Velocity™ Percutaneous AVF System 08/22/2025
Rezo Therapeutics Appoints Derek Hicks as CEO
Rezo Therapeutics Appoints Derek Hicks as CEO 08/22/2025
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition 08/14/2025
Tahoe Therapeutics Raises $30M to Build World’s Largest Dataset for Training AI Models of Human Cell
Tahoe Therapeutics Raises $30M to Build World’s Largest Dataset for Training AI Models of Human Cell 08/11/2025
Do These Two Cancer Drugs Have What It Takes to Beat Alzheimer’s?
Do These Two Cancer Drugs Have What It Takes to Beat Alzheimer’s? 08/05/2025
Dr. Nicole Jiam, Director of the UCSF Otolaryngology Innovation Center, receives a $1.25M National Science Foundation SBIR Phase II award.
Dr. Nicole Jiam, Director of the UCSF Otolaryngology Innovation Center, receives a $1.25M National Science Foundation SBIR Phase II award. 07/31/2025
Welcome the New CEO and Board Director of Exai Bio
Welcome the New CEO and Board Director of Exai Bio 07/24/2025
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression 07/16/2025
Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy
Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy 07/15/2025